- Ut imperdiet leo id lorem fermentum consectetur.
- Ut vitae orci et dui varius tincidunt.
- Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Digital & Innovation
Pfizer partners to advance machine learning for drug discovery

Digital & Innovation: A biotechnology company specialising in machine learning (ML) solutions for preclinical drug discovery, announced a strategic partnership with Pfizer with the goal of accelerating small molecule drug discovery by developing a platform technology based on generative chemistry.
PostEra’s ML technology is intended to accelerate the drug discovery process by designing novel molecular structures with optimised potency and drug-like properties.
Through the collaboration, the companies will leverage Pfizer’s extensive data and expertise with PostEra’s technology capabilities to advance the science of generative chemistry to produce state-of-the-art, scalable models that could potentially be deployed across in-house, preclinical drug discovery efforts.
PostEra will receive an upfront payment and is eligible to receive additional payments as the project progresses. PostEra will also retain ownership rights to all algorithms developed during the collaboration.
“We believe that our investments in machine learning technologies could potentially help us expedite preclinical drug discovery. PostEra’s technology complements this effort, and we look forward to seeing the results of the collaboration,” said Charlotte Allerton, Head of Medicine Design, Pfizer.
“PostEra is delighted to be working with Pfizer to solve some of the key pain points in preclinical drug discovery,” said Aaron Morris, CEO of PostEra. “As a team we are proud to be entering this collaboration and will be leveraging PostEra’s many advances in machine learning to help Pfizer accelerate progress toward novel therapeutics.”
Digital & Innovation

Shifts in Pharma’s digital health landscape – Deep dive with Dr Ramin Rafiei
In this Health Industry Hub interview, Dr Ramin Rafiei takes us on a deep dive into the current digital health […]
MoreNews & Trends - Pharmaceuticals

Boehringer Ingelheim reduces carbon footprint with launch of reusable inhaler
Pharma News: Boehringer Ingelheim has reinforced its commitment to increased sustainability within the healthcare sector, launching a more eco-friendly version […]
MoreMedical

$1.3 billion manufacturing funding opens for medicines and medical devices
Medical News: The Morrison Government is backing Australia’s medical products manufacturers to grow and create new jobs, with applications for […]
MoreNews & Trends - Medical Technology

$100 million funding for major advances in medical technology
MedTech News: $100 million is being invested into the development of new medical technologies to improve diagnosis and treatment of […]
More